Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Expert Opinion on Drug Safety|December 27, 2024
Safety profile of isocitrate dehydrogenase inhibitors in cancer therapy: a pharmacovigilance study of the FDA Adverse Event Reporting SystemYiming Fu, Ruxue Lv, Ruizhen Li, et al.
Frontiers in Genetics|June 6, 2020
CircRNA_103809 Suppresses the Proliferation and Metastasis of Breast Cancer Cells by Sponging MicroRNA-532-3p (miR-532-3p)Minfeng Liu, Can Luo, Jianyu Dong, et al.
Oncology Research|March 25, 2017
Clinical Value of Capecitabine-Based Combination Adjuvant Chemotherapy in Early Breast Cancer: A Meta-Analysis of Randomized Controlled TrialsGuanling Chen, Zhaoze Guo, Minfeng Liu, et al.
Gland Surgery|November 4, 2021
Preparing PAMAM-NK4 nano complexes and examining their in vitro growth suppression effects in breast cancerMinfeng Liu, Zhaoze Guo, Jiangqin Liu, et al.
The Journal of International Medical Research|September 16, 2021
Integrated analyses of long noncoding RNAs and mRNAs in the progression of breast cancerJingyun Guo, Huining Lian, Minfeng Liu, et al.
Annals of Translational Medicine|May 14, 2021
Methylated biomarkers for breast cancer identified through public database analysis and plasma target capture sequencingCan Luo, Jiaheng Huang, Zhaoze Guo, et al.
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|July 8, 2016
Experimental Study of Magnetic Multi-Walled Carbon Nanotube-Doxorubicin Conjugate in a Lymph Node Metastatic Model of Breast CancerJian Ji, Minfeng Liu, Yue Meng, et al.
Molecular Medicine Reports|June 3, 2021
MAPK4 silencing together with a PARP1 inhibitor as a combination therapy in triple‑negative breast cancer cellsXiaoqi Zeng, Shanshan Jiang, Simin Ruan, et al.
Nan Fang Yi Ke Da Xue Xue Bao = Journal of Southern Medical University|June 28, 2014
[Differentially expressed genes and potential signaling pathway in Asian people with breast cancer by preliminary analysis of a large sample of the microarray data]Lujia Chen, Changsheng Ye, Zhongxi Huang, et al.
Drug Delivery|December 30, 2021
Biodegradable hollow mesoporous organosilica nanotheranostics (HMONs) as a versatile platform for multimodal imaging and phototherapeutic-triggered endolysosomal disruption in ovarian cancerPengfei Li, Bingquan Lin, Zhian Chen, et al.
Pageof 3